Bearish Trend: TryHard's 15min chart shows KDJ Death Cross, Bearish Marubozu

According to the 15-minute chart of TryHard, a KDJ Death Cross and Bearish Marubozu have occurred at 10:30 on October 10, 2025. This indicates a shift in the momentum of the stock price towards a downward trend, with a potential for further decline. Sellers have taken control of the market, and there is a likelihood of continued bearish momentum.

IonQ, Inc. (IONQ), a leading quantum computing company, has successfully priced a $2.0 billion equity offering. The offering consists of 16,500,000 shares of stock at $93 per share, pre-funded warrants to purchase 5,054,000 shares at $93 per warrant, and seven-year warrants to purchase an additional 43,010,800 shares at an exercise price of $155 per share. The exercise prices represent 20% and 100% premiums to the company's closing stock price on October 9, respectively IonQ Prices $2 Bln Equity Offering At 93/shr^[1].

Chairman and CEO Niccolo de Masi highlighted that the $2 billion investment will accelerate global growth and quantum commercialization, positioning IonQ as one of the few companies capable of delivering advanced computing, networking, and sensing solutions across multiple platforms IonQ Prices $2 Bln Equity Offering At 93/shr^[1]. In the pre-market trading session, IonQ's stock was trading at $76.43 on the New York Stock Exchange, down by 1.40% from its closing price on October 9 IonQ Prices $2 Bln Equity Offering At 93/shr^[1].

Meanwhile, ZimVie Inc. (ZIMV), a global leader in dental implants, has been in the spotlight due to its acquisition by ARCHIMED. ZimVie reported its Q2 2025 financial results, showing a net loss of $3.8 million, a slight improvement from the $9.6 million loss in Q2 2024. The company also announced a definitive agreement to be acquired by ARCHIMED for $19.00 per share in cash, representing a 99% premium to its 90-day volume-weighted average price ZIMVIE INC Stock Price, News & Analysis^[2].

The acquisition is expected to close by year-end 2025, subject to stockholder and regulatory approvals. Upon completion, ZimVie will become private and delist from NASDAQ ZIMVIE INC Stock Price, News & Analysis^[2]. The company has also expanded its dental implant presence in China through an exclusive distribution agreement with Osstem Implant, leveraging Osstem's extensive distribution network in over 90 Chinese cities ZIMVIE INC Stock Price, News & Analysis^[2].